iCAD任命Mark Koeniguer为CCO

2025-04-08 23:27

iCAD (NASDAQ:ICAD) on Tuesday announced the appointment of Mark Koeniguer as chief commercial officer (CCO), to lead the next phase of global growth for iCAD.
As CCO at iCAD, Koeniguer will assume responsibilities for revenue growth across North America and around the globe.
In his new role, Koeniguer will have oversight of the commercial sales teams, partnerships, operations and customer success, said the company.
Most recently, Koeniguer served as CEO of ScreenPoint Medical. He previously held executive leadership roles at Riverain Technologies, Volpara Health, R2 Technology, Stereotaxis and GE Healthcare.
ICAD is +1.75439% to $1.74.
Source: Press Release

More on iCAD